AI-Derived Software in Chest X-Ray Analysis: A NICE Perspective

By Staff Writer

October 10, 2023

A recent update has been published by NICE (National Institute for Health and Care Excellence). It described the use of artificial intelligence (AI)-derived software in analysing chest X-rays for suspected lung cancer. This has been under scrutiny in primary care referrals. This initiative is part of the NHS’s ambition to diagnose 75% of all cancers at stages 1 or 2 by 2028.

Potential Benefits of AI-Derived Software in Chest X-Ray Analysis

The AI-equipped software can detect lung abnormalities in chest X-ray images automatically. It can assist radiologists and reporting radiographers in interpreting these images. This aids in making clinical decisions about the need for further investigations or CT scans. The software can distinguish between normal and abnormal images. It can also highlight suspected abnormalities. It allows for prioritizing the review of chest X-rays. This could potentially accelerate the referral process to CT scans. 


However, the committee noted that trust in AI-derived software for patients and healthcare professionals was crucial for its efficient use. This would require standardisation of technologies and further research in the setting of interest. Prospective studies need to be conducted in a population referred from primary care to reflect how the NHS would use the software in clinical practice. 


The committee also highlighted that AI-derived software could be particularly beneficial for certain groups. It could improve lung cancer detection in people with underlying lung conditions. These include asthma, chronic obstructive pulmonary disease (COPD), people with a family background of lung cancer, and younger women who do not smoke.

Potential Risks and Challenges in the Use of AI-Derived Software

However, the committee also pointed out potential risks associated with using AI-derived software. These include the cost of the AI-derived software. This may not be offset by cost and resource savings later in the pathway. Lower specificity to detect cancerous nodules and other abnormalities that suggest cancer could result in more people without cancer having CT scans. This could have cost and disutility implications.

In conclusion, while AI-derived software shows promise in aiding the early detection of lung cancer, more research and standardisation are needed to ensure its efficient and effective use in clinical practice. You should also carefully consider the potential benefits and risks associated with its use.

Reference url

Recent Posts

perioperative immunotherapy bladder cancer
       

FDA Approves Perioperative Immunotherapy for Bladder Cancer: A Breakthrough in MIBC Treatment

🚀 Are we witnessing a new era in bladder cancer treatment?

The FDA’s recent approval of durvalumab as the first perioperative immunotherapy for muscle-invasive bladder cancer (MIBC) could revolutionize outcomes for patients facing this formidable diagnosis. With significant improvements in event-free survival and overall survival over standard chemotherapy, this groundbreaking treatment offers new hope 🎉.

Curious about how this could shape the future of cancer care? Dive into the full article to uncover the potential impacts on clinical practice and health economics.

#SyenzaNews #oncology #HealthEconomics

value-based drug pricing
      

Optimizing Value-Based Drug Pricing in Japan with MARIE Framework

🔍 Are we pricing drugs based on true value?

The introduction of the MARIE framework in Japan revolutionizes value-based drug pricing by considering not just costs, but the actual benefits drugs provide to patients and society. This innovative approach significantly adjusts prices based on updated clinical data and allows for more equitable access to therapies.

Curious about how MARIE can reshape drug pricing and pharmaceutical innovation? Dive into the full article for insights!

#SyenzaNews #HealthEconomics #MarketAccess

modifiable risk factors
        

Targeting Shared Risk Pathways to Prevent Stroke, Dementia, and Depression

🧠 What if addressing just a few key lifestyle factors could significantly reduce the risk of stroke, dementia, and depression in older adults?

A recent systematic review has identified 17 **modifiable risk factors**, revealing the interconnected nature of these age-related brain diseases and offering crucial insights for preventive strategies. By focusing on aspects such as blood pressure management, nutrition, and physical activity, we can enhance quality of life for our aging population.

Dive into the article to explore how these findings could shape future healthcare models.

#SyenzaNews #HealthEconomics #HealthcareInnovation #DigitalTransformation

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.